CAMBRIDGE, MASSACHUSETTS — November 18, 2025 — Leads & Copy — Moderna, Inc. (Nasdaq:MRNA) has announced its participation in the upcoming Piper Sandler’s 37th Annual Healthcare Conference on Tuesday, December 2nd at 11:00am ET.
A live webcast of the presentation will be accessible in the Investors section of the Moderna website under “Events and Presentations”. Following the presentation, a replay of the webcast will be archived on Moderna’s website for a minimum of 30 days.
Moderna is known as a leader in mRNA medicine. By advancing mRNA technology, Moderna is transforming the creation of medicines for disease treatment and prevention. With over a decade of work in science, technology, and health, the company has rapidly developed effective medicines, including early COVID-19 vaccines.
Moderna’s mRNA platform facilitates the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, and autoimmune diseases. Driven by its values and mindsets, Moderna aims to impact human health positively through mRNA medicines.
Investors can contact Lavina Talukdar, Senior Vice President & Head of Investor Relations, at 617-209-5834 or Lavina.Talukdar@modernatx.com.
Source: Moderna, Inc.
